Anthem’s IPO Charts a New Course—Can India’s CRDMO Star Deliver?

Unknown Apr 02, 2026 850 Views

Anthem Biosciences, a leading CRDMO player in India, is set to launch its ₹3,395 crore initial public offering (IPO) from July 14 to July 16. The IPO is entirely an offerforsale (OFS) of 5.96 crore shares by existing shareholders, with no fresh issue component. Key Dates and Struct...